Authors : Jean Caude Bucumi; Inas Ouggane; Sylvestre Nimubona; Mwana-Yile Hassan; B. Raissa; Sana Jebbar; Hanani Badi; Fatima Ihbibane; Ahd Oulad Lahsen; Mustapha Sodqi; Latifa Marih

Volume/Issue : Volume 11 - 2026, Issue 2 - February

Google Scholar : https://tinyurl.com/237ryv8k

Scribd : https://tinyurl.com/3cbsdd55

DOI : https://doi.org/10.38124/ijisrt/26feb004

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Neurosyphilis remains a complex diagnostic entity due to the wide variability of its clinical manifestations and the frequency of normal brain imaging, particularly in the early stages of the disease. Despite therapeutic and diagnostic advances, it remains a public health problem in the context of a global resurgence of syphilis. We report a series of four cases of neurosyphilis hospitalized at the Ibn Rochd University Hospital in Casablanca between 2024 and 2025. The patients were between 34 and 48 years old, including one patient recently diagnosed with HIV and three immunocompetent patients. All presented with neurological manifestations dominated by persistent headaches, with a completely normal brain CT scan. Serological tests showed positivity for TPHA and VDRL in serum and cerebrospinal fluid, confirming the diagnosis. The outcome under treatment with intravenous penicillin G was favorable in all patients. This case series highlights the importance of considering neurosyphilis in any case of unexplained neurological symptoms, including in immunocompetent patients and in the absence of radiological abnormalities.

Keywords : Neurosyphilis, TPHA, VDRL, HIV, Cerebrospinal Fluid, Case Series.

References :

1. Hamill M.M., et al., “Neurosyphilis: State-of-the-Art Review,” Clinical Infectious Diseases, vol. 78, no. 2, pp. 245–256, 2024.
2. Wu S., et al., “Neurosyphilis: Diagnosis and Management,” Frontiers in Neurology, vol. 15, pp. 1–12, 2024.
3. Marra C.M., “Neurosyphilis,” Continuum, vol. 29, no. 4, pp. 1023–1042, 2023.
4. Bădărău A., et al., “Clinical Spectrum of Neurosyphilis,” BMC Neurology, vol. 24, pp. 112–120, 2024.
5. Ghanem K.G., “Syphilis and HIV Coinfection,” The Lancet Infectious Diseases, vol. 23, no. 6, pp. e150–e160, 2023.
6. Zhang Y., et al., “Radiological Features of Neurosyphilis,” BMC Neurology, vol. 24, pp. 89–97, 2024.
7. Fioriti G., et al., “Clinical Manifestations of Neurosyphilis,” Clinical Neurology and Neurosurgery, vol. 231, pp. 107–115, 2023.
8. Singh A.E., et al., “Systemic Manifestations of Syphilis,” CMAJ, vol. 195, no. 12, pp. E420–E427, 2023.
9. Xu H., et al., “CSF VDRL Performance in Neurosyphilis,” Scientific Reports, vol. 14, pp. 3345–3352, 2024.
10. Ito H., et al., “Advances in Neurosyphilis Diagnostics,” Clinical Infectious Diseases, vol. 79, no. 1, pp. 98–105, 2024.
11. Centers for Disease Control and Prevention, “Sexually Transmitted Infections Treatment Guidelines,” CDC, 2024.
12. Tuddenham S., et al., “Syphilis Resurgence and Neurological Complications,” The Lancet, vol. 402, pp. 121–130, 2023.
13. Workowski K.A., et al., “Sexually Transmitted Infections Treatment Guidelines,” MMWR, vol. 73, no. 1, pp. 1–187, 2024.
14. Ropper A.H., “Neurosyphilis in Modern Neurology,” New England Journal of Medicine, vol. 389, pp. 455–463, 2023.
15. Lafon-Desmurs B., et al., “Neurosyphilis: Diagnostic Challenges,” Revue Neurologique, vol. 180, no. 5, pp. 312–320, 2024.